Long-Term Business Development
We build enduring relationships rather than transactions, with strategies that create value for partners and the communities they operate in.

Pharmaceutical consultancy · Denmark
We connect pharmaceutical innovation with global reach, championing GMP standards, climate responsibility and patient safety for a healthier tomorrow.
Empowering sustainable growth
Leverage our expert consultancy, technology transfer, and ethical frameworks to expand your market presence and deliver life-changing therapies worldwide.
About NPC
Nordic PharmaTech Consultancy (NPC) is dedicated to bridging the gap between Scandinavian pharmaceutical innovation and emerging markets. Guided by a commitment to quality, ethics, and human rights, we strive to foster sustainable, long-term partnerships that positively impact patients, communities, and industry stakeholders worldwide.


Our story
Over the past twenty years of our career, we have developed and refined a comprehensive framework called the Integration Management Framework — a practical framework designed to bring together the commercial, operational, technical, QA & regulatory, and partnership elements required to turn an investment ambition into a successful CMO business.
We developed this framework through real-world experience and, over time, successfully applied it to achieve the outcome we were seeking: building a bridge between emerging markets and the Western world, connecting investors and local businesses with the knowledge, technologies, standards, and partnerships needed to create sustainable pharmaceutical businesses.
We have made many of the mistakes that come with building and developing businesses at an early stage. Those experiences taught us what actually drives value, what moves the numbers, and, equally importantly, what can prevent a promising business from reaching its potential.
Today we are at a point in our careers where we want to bring that experience to a company that is ready to scale. Our aim is not simply to provide advice, but to help build the structures, partnerships, and execution capabilities that allow investors and companies to translate strategy into measurable results, and ultimately turn opportunities in emerging markets into businesses that can meet Western standards and compete internationally.
How we work
We build enduring relationships rather than transactions, with strategies that create value for partners and the communities they operate in.
Quality, climate responsibility and human rights are not appended to the commercial plan. They set its boundaries.
Open books and plain assessments with the companies we work alongside, including when the answer is no.
GMP is a shared commitment across every partner in the chain, not a document produced before an audit.
The Framework
Commercial plans, technical design, quality systems and partnerships are usually built by different people, at different times, to different standards. The gap between them is where value is lost. The Integration Management Framework governs those handovers, so a decision taken in one element is tested against the other four before it becomes expensive.
The market case that justifies the investment: demand, positioning, pricing and the route to a sustainable order book.
Capacity, supply chain and the day-to-day production model that has to hold once the plant is running, not only on paper.
Process design, equipment and technology transfer - moving a product into a new site without losing its integrity.
The quality system, GMP posture and regulatory pathway that decide whether the output is accepted by Western markets.
Alignment between investors, local operators and international partners - the element most often left to chance.
Capabilities
Five services that map directly onto the five elements of the Framework, delivered together rather than in isolation.

Direction
To bridge Scandinavia and emerging markets, so that reliable medicine reaches the patients and people who need it.
To enable healthy commercial and production environments for Scandinavian pharmaceutical operations abroad.
A sustainable business model built on GMP-based manufacturing that holds up to international inspection.
Enable local production, implement technology transfer, and grow Denmark's presence in emerging markets.
Management
Engagements are led by the partners, not handed down. Between them they carry more than sixty years in pharmaceutical operations.

Partner
32 years of experience in business development, production, CMO and project management, delivered across Denmark, Norway, France, the USA, the Middle East, India, Russia and North Africa.
MSc in Management and Process Improvement · BSc in Process Engineering

Partner
More than 32 years of experience working with major pharmaceutical companies in a range of positions across Denmark, Greece, Turkey and the UAE.
MSc, Royal School of Pharmaceutical Science, University of Copenhagen
Contact
We value open communication and are eager to discuss how we can support your pharmaceutical initiatives — whether you are interested in our consultancy services, exploring partnership opportunities, or simply have questions.
Monday - Friday, 08:00 - 18:00 CET